Pokmon Card Market Roars Back Nostalgia HighProfile Sales and Speculation Drive MultiMillion Dollar Trades SEBI Bars Seven Family Members in Social Media Stock PumpandDump Case Alleges 2025 Crore Illegal Gains Quiz Set to Shut All Stores After 33 Years Amid Intensifying Retail Challenges Jim Cramer Comments on ServiceNows NOW Stock Performance Morgan Stanley Lowers Southern Company Price Target Cites Utilities Underperformance US Stocks Reach New Highs as AI Rally Shows Signs of Cooling Wetouch Technology Inc Q1 1996 Earnings EPS Falls Short of Estimates Stock Rises on Speculative Optimism Knowles Q1 2026 Earnings EPS Surges Past Estimates Stock Rises 4 BNTX Q1 2026 Earnings NarrowerThanExpected Loss as BioNTech Focuses on Pipeline Progress RSG Q1 2026 Earnings Earnings Beat Estimates Amid Solid Operational Execution PAM Q1 2026 Earnings Staggering EPS Beat as Operating Performance Surges BRC Group Holdings Inc 550 Senior Notes Due 2026 RILYK Q1 2024 Earnings Net Loss Widens Bond Prices Edge Higher Nuveen Arizona Quality Municipal Income Fund NAZ Holds Steady Near Support Amid Modest Decline IP Strategy Holdings IPST Declines Over 6 Testing Key Support Amid Selling Pressure NAPCO Security Technologies NSSC Climbs 196 as Bullish Momentum Builds Alliance Resource Partners ARLP Inches Higher as Support and Resistance Levels Hold BXP Inc BXP Holds Steady Near Support as Trading Activity Remains Subdued Quantumsphere Acquisition Corp QUMS Holds Steady at 1019 as Trading Range Narrows Avis Budget Group CAR Surges Past Support Tests Key Resistance Zone NAPCO Security Technologies NSSC Slips 197 as Stock Tests Key Support Levels CNB Financial CCNE Slips Marginally as Price Stays Between Key Support and Resistance Imax Corporation IMAX Surges 15 Breakout Momentum or Overextension Community Health Systems CYH Faces Renewed Selling Pressure Tests Key Support Dow Jones Ends at Record High While AILed Rally Cools SP 500 and Nasdaq Stay Flat Precigen Q1 2026 Earnings Narrowed Loss Exceeds Expectations as Stock Rises Intellia Therapeutics NTLA Gains 186 as Gene Editing Stocks Find Support